Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1200 | 2.310 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 880 | 2.040 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 727 | 1.770 |
Why?
|
| Gait | 6 | 2021 | 382 | 1.270 |
Why?
|
| Hippocampus | 6 | 2020 | 200 | 1.220 |
Why?
|
| Cognition | 10 | 2022 | 941 | 1.130 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 1307 | 1.090 |
Why?
|
| Exercise | 6 | 2021 | 398 | 1.040 |
Why?
|
| Aging | 8 | 2021 | 1098 | 0.990 |
Why?
|
| Aged, 80 and over | 28 | 2022 | 3783 | 0.980 |
Why?
|
| Postural Balance | 3 | 2021 | 100 | 0.840 |
Why?
|
| Independent Living | 5 | 2021 | 225 | 0.830 |
Why?
|
| Neuropathology | 3 | 2021 | 60 | 0.800 |
Why?
|
| Postmortem Changes | 2 | 2016 | 23 | 0.800 |
Why?
|
| Male | 35 | 2022 | 12629 | 0.700 |
Why?
|
| Female | 35 | 2022 | 13124 | 0.690 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 38 | 0.670 |
Why?
|
| White Matter | 5 | 2018 | 109 | 0.670 |
Why?
|
| Humans | 47 | 2022 | 23331 | 0.640 |
Why?
|
| Aged | 25 | 2022 | 7552 | 0.600 |
Why?
|
| Autopsy | 9 | 2021 | 257 | 0.590 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 48 | 0.570 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 39 | 0.550 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 94 | 0.520 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 569 | 0.510 |
Why?
|
| Motor Activity | 1 | 2018 | 276 | 0.490 |
Why?
|
| Knee Joint | 1 | 2019 | 572 | 0.440 |
Why?
|
| Thalamus | 3 | 2021 | 15 | 0.440 |
Why?
|
| Atrophy | 3 | 2021 | 66 | 0.440 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 164 | 0.400 |
Why?
|
| Accelerometry | 4 | 2021 | 78 | 0.370 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 59 | 0.360 |
Why?
|
| Walking | 4 | 2022 | 238 | 0.350 |
Why?
|
| Neuroimaging | 3 | 2021 | 102 | 0.350 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1050 | 0.330 |
Why?
|
| Walking Speed | 2 | 2021 | 34 | 0.330 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 159 | 0.320 |
Why?
|
| Gray Matter | 3 | 2021 | 39 | 0.320 |
Why?
|
| Formaldehyde | 1 | 2009 | 7 | 0.310 |
Why?
|
| RNA, Messenger | 2 | 2022 | 285 | 0.300 |
Why?
|
| Cohort Studies | 8 | 2020 | 1429 | 0.300 |
Why?
|
| Temporal Lobe | 2 | 2020 | 63 | 0.280 |
Why?
|
| Parkinson Disease | 4 | 2021 | 586 | 0.280 |
Why?
|
| Brain Mapping | 3 | 2017 | 123 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 158 | 0.280 |
Why?
|
| Dementia | 2 | 2022 | 388 | 0.270 |
Why?
|
| Organ Size | 3 | 2015 | 84 | 0.230 |
Why?
|
| Nerve Net | 2 | 2021 | 34 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 866 | 0.210 |
Why?
|
| Sclerosis | 3 | 2019 | 56 | 0.200 |
Why?
|
| Transcriptome | 2 | 2022 | 55 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 128 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 88 | 0.190 |
Why?
|
| Tremor | 2 | 2021 | 93 | 0.180 |
Why?
|
| Proteome | 1 | 2022 | 23 | 0.180 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 7 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 56 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 99 | 0.180 |
Why?
|
| Cognition Disorders | 3 | 2017 | 688 | 0.180 |
Why?
|
| Motor Skills | 1 | 2021 | 37 | 0.170 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 6 | 0.170 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 83 | 0.170 |
Why?
|
| Neuropeptides | 2 | 2019 | 22 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 22 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 49 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 178 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 56 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2021 | 26 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 93 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 127 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 61 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 86 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 211 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 6 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 104 | 0.160 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 11 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 21 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 119 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 57 | 0.150 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 11 | 0.150 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 86 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 39 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 99 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 79 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 11 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 218 | 0.140 |
Why?
|
| Femur | 1 | 2020 | 304 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 19 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 63 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 192 | 0.130 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 34 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 272 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 29 | 0.130 |
Why?
|
| Plasmacytoma | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 14 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 73 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 127 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 151 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 59 | 0.120 |
Why?
|
| Neocortex | 1 | 2016 | 22 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 314 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 1674 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 35 | 0.120 |
Why?
|
| Adult | 8 | 2021 | 7070 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 274 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 309 | 0.120 |
Why?
|
| Locomotion | 1 | 2014 | 20 | 0.110 |
Why?
|
| Shoulder Joint | 1 | 2019 | 507 | 0.100 |
Why?
|
| Middle Aged | 6 | 2021 | 8055 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2011 | 74 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 33 | 0.080 |
Why?
|
| Mortality | 2 | 2021 | 74 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 1998 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 5 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 391 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 819 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 147 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 230 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 139 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 593 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 594 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 369 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 59 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 27 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 87 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 19 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 37 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 195 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 73 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 104 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 9 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 2 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 9 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 7 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 15 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 12 | 0.040 |
Why?
|
| Software | 1 | 2019 | 50 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 158 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 51 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 774 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 525 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 641 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 101 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 355 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 481 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 25 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 636 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 813 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 34 | 0.030 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 112 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 220 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 24 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 31 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1441 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 56 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 740 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 163 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 61 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 166 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 149 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 246 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 125 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1523 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1829 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 80 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 103 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 12 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 15 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 268 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 155 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2013 | 43 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 240 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 275 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 1916 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 452 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3040 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 536 | 0.020 |
Why?
|